These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 17575721

  • 1. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K.
    Int J Hyperthermia; 2007 Feb; 23(1):29-35. PubMed ID: 17575721
    [Abstract] [Full Text] [Related]

  • 2. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
    Masunaga S, Sakurai Y, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Nagasawa H, Uto Y, Hori H, Ono K.
    Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H.
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [Abstract] [Full Text] [Related]

  • 4. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [Abstract] [Full Text] [Related]

  • 5. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y.
    Jpn J Cancer Res; 2000 May 01; 91(5):566-72. PubMed ID: 10835503
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential.
    Masunaga S, Liu Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K.
    Int J Hyperthermia; 2012 May 01; 28(7):636-44. PubMed ID: 22946564
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
    Masunaga S, Tano K, Watanabe M, Kashino G, Suzuki M, Kinashi Y, Ono K, Nakamura J.
    Br J Radiol; 2009 May 01; 82(977):392-400. PubMed ID: 19153181
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
    Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K.
    Int J Radiat Biol; 2019 Dec 01; 95(12):1708-1717. PubMed ID: 31545117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
    Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Int J Hyperthermia; 1999 Dec 01; 15(1):7-16. PubMed ID: 10193753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):996-1007. PubMed ID: 11572769
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations.
    Masunaga S, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K.
    Radiat Med; 2007 Oct 01; 25(8):417-25. PubMed ID: 17952547
    [Abstract] [Full Text] [Related]

  • 16. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
    Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Br J Radiol; 2000 Sep 01; 73(873):978-86. PubMed ID: 11064652
    [Abstract] [Full Text] [Related]

  • 17. Applicability of combination with tirapazamine in boron neutron capture therapy.
    Masunaga S, Ono K, Sakurai Y, Hori H, Kobayashi T, Takagaki M, Suzuki M, Kinashi Y, Akaboshi M.
    Jpn J Cancer Res; 1998 Jul 01; 89(7):768-74. PubMed ID: 9738984
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Int J Hyperthermia; 2006 Jun 01; 22(4):287-99. PubMed ID: 16754350
    [Abstract] [Full Text] [Related]

  • 20. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
    Masunaga S, Ono K, Hori H, Shibata T, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M.
    Jpn J Cancer Res; 1997 Sep 01; 88(9):907-14. PubMed ID: 9369940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.